Form 4: Verastem CEO Sells 6,000 Shares Under 10b5-1 Plan
Insider Trading Report
Verastem Inc.'s President and CEO, Dan Paterson, reported the sale of 6,000 shares of common stock across three transactions in early December 2025, executed under a pre-arranged Rule 10b5-1 trading plan.
Summary
- Dan Paterson, President and CEO, and a Director of Verastem, Inc. (VSTM), reported the sale of 6,000 shares of common stock.
- The sales occurred on December 5, 2025 (2,000 shares at $10.61), December 8, 2025 (2,000 shares at $10.50), and December 9, 2025 (2,000 shares at $10.25).
- These transactions were executed pursuant to a Rule 10b5-1 trading plan, indicating they were pre-scheduled.
- Following these sales, Mr. Paterson beneficially owns 414,818 shares of Verastem common stock.
Sentiment
Score: 4
Explanation: The sentiment is moderately negative due to insider selling, although the impact is mitigated by the disclosure that sales were made under a Rule 10b5-1 plan, indicating pre-scheduled transactions rather than a reaction to immediate negative news.
Negatives
- Insider selling by the President and CEO, Dan Paterson, totaling 6,000 shares.
- The sales occurred at prices ranging from $10.25 to $10.61 per share.
Stakeholder Impact
- Shareholders: May interpret insider selling as a lack of confidence, potentially leading to downward pressure on the stock price, though the 10b5-1 plan mitigates this to some extent.
Key Dates
| Date | Description |
|---|---|
| 12/05/2025 | Sale of 2,000 shares of Common Stock by Dan Paterson at $10.61 per share. |
| 12/08/2025 | Sale of 2,000 shares of Common Stock by Dan Paterson at $10.50 per share. |
| 12/09/2025 | Sale of 2,000 shares of Common Stock by Dan Paterson at $10.25 per share. |
| 12/09/2025 | Date of signature for the Form 4 filing. |
Recommendation
holdWhile insider selling by a CEO is generally a negative signal, the fact that these sales were executed under a pre-arranged Rule 10b5-1 trading plan suggests they are not a reaction to new, adverse information. The volume of shares sold (6,000) is relatively small compared to the CEO's remaining beneficial ownership (414,818 shares), indicating a minor reduction in stake rather than a significant divestment. Therefore, a 'hold' recommendation is appropriate, advising investors to monitor future filings and company performance rather than reacting solely to these planned sales.
Keywords
Verastem, VSTM, Insider Trading, Form 4, Stock Sale, CEO, Dan Paterson, 10b5-1 Plan, Equity Transaction
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.